![Erik Berglund](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Erik Berglund formerly worked at Gilead Sciences, Inc., as Senior Director-Regulatory Affairs and Vistagen Therapeutics, Inc., as Senior Vice President-Global Regulatory Affairs from 2021 to 2025.
Dr. Berglund received his doctorate degree from Umea Universitet.
Eerdere bekende functies van Erik Berglund
| Bedrijven | Functie | Einde |
|---|---|---|
| VISTAGEN THERAPEUTICS, INC. | Algemeen Adviseur | 10-01-2025 |
| GILEAD SCIENCES, INC. | Algemeen Adviseur | - |
Opleiding van Erik Berglund
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
8
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Umea Universitet
 Umea Universitet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VistaGen Therapeutics, Inc.
 VistaGen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops central nervous system therapies | Health Technology |
